STOCK TITAN

Ligand Pharms CVR (LGNDZ) Debt by Year

LGNDZ OTC

Ligand Pharms Inc CVR held $174.9M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Ligand Pharms Inc CVR has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $174.9M
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LGNDZ Debt & Cash by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY19FilingFY1810-QFY1710-QFY1610-KFY1510-KFY14FilingFY13FilingFY1210-KFY11Filing
Long-Term DebtN/AN/AN/A$0-100.0%$320.7M-27.5%$442.3M-30.8%$639.0M+4.8%$609.9Mn/m$0N/A$0-100.0%$195.9MN/A$27.5M+35.6%$20.3M
Cash & Equivalents$174.9M+141.9%$72.3M+215.0%$23.0M-49.0%$45.0M+130.5%$19.5M-59.0%$47.6M-33.4%$71.5M-38.9%$117.2M+468.2%$20.6M+10.0%$18.8M-80.8%$97.4M-39.2%$160.2M+1276.4%$11.6M-6.0%$12.4M+75.8%$7.0M

LGNDZ Debt & Cash by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Long-Term Debt$679.9M$1.1BN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$56.0M-59.9%$1.0B+1387.7%$115.1M+139.8%$174.9M+141.9%$139.4M+119.1%$67.7M+273.1%$48.0M-4.2%$72.3M+215.0%$63.6M+230.1%$18.1M-36.2%$50.1M-43.5%$23.0M-49.0%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Ligand Pharms Inc CVR financials

Frequently Asked Questions

Ligand Pharms Inc CVR held $174.9M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.

Ligand Pharms Inc CVR (LGNDZ) reported $679.9M in long-term debt in Q3 2026.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Ligand Pharms Inc CVR (LGNDZ) reported on that line in every period on record.